GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (XPAR:ALCLS) » Definitions » Net Interest Income (for Banks)

Cellectis (XPAR:ALCLS) Net Interest Income (for Banks)


View and export this data going back to 2007. Start your Free Trial

What is Cellectis Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Cellectis Business Description

Industry
Traded in Other Exchanges
Address
8, rue de la Croix Jarry, Paris, FRA, 75013
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.